uniQure NV
QURE
23.14
+0.08
+0.35%
uniQure NV
US · QURE
#2954 by market cap
Listed 1970
23.14
+0.08
+0.35%
Live - 5344 symbols - heartbeat 31s ago
· 2026-10-08 07:25
Pre-market
23.13
-0.04%
After-hours
23.07
-0.30%
Overnight
22.85
-1.25%
- Market cap
- 1.61B
- P/E (TTM)i
- -5.70
- P/Bi
- 4.95
- EPSi
- -3.46
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on QURE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.9 percentage points.
Institutional ownership
- Held by institutions
- 96.79% -0.92pp
- Institutions
- 298 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Hedge Fund42.05%
Mutual Fund38.14%
VC/PE Fund6.06%
Private Company4.89%
Public Company4.76%
Individual/Insider1.69%
Government Pension Fund0.52%
Family Office/Trust0.27%
Insurance Company0.11%
Other1.52%
Top holders as of 2026-06-30
Avoro Capital Advisors LLC
9.70% · 6.73M sh
J.P. Morgan Asset Management, Inc.
6.81% · 4.73M sh
RTW Investments, LP
5.68% · 3.94M sh
State Street Global Advisors
4.19% · 2.90M sh
abrdn plc
4.11% · 2.85M sh
BlackRock
2.71% · 1.88M sh
OrbiMed Advisors LLC
2.61% · 1.81M sh
Jane Street Group, LLC
2.32% · 1.61M sh
Jennison Associates LLC
2.25% · 1.56M sh
Boxer Capital Management, LLC
2.17% · 1.50M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 19 buys · 31 sells
| Name | Role | Stake |
|---|---|---|
| Matthew Kapusta | Chief Executive Officer | 0.75% |
| Walid Abi-Saab | Chief Medical Officer | 0.21% |
| Christian Klemt | CFO, Principal Financial Officer & GM of Amsterdam Site | 0.18% |
| Kylie O'Keefe | Chief Customer & Strategy Officer | 0.16% |
| Jeannette Potts | Chief Legal & Compliance Officer | 0.08% |
| Madhavan Balachandran | Independent Non-Executive Director | 0.06% |
| Jeremy Springhorn | Independent Non-Executive Director | 0.05% |
| David Meek | Independent Chairperson | 0.05% |
| Leonard Post | Independent Non-Executive Director | 0.04% |
| Rachelle Jacques | Non-Executive Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-01 | Matthew Kapusta | Chief Executive Officer | Derivative Exercise and Sale | -21,082 | $19.39–45.89 |
| 2026-06-29 | Jack Kaye | Independent Non-Executive Director | Derivative Exercise and Sale | -21,167 | $20.18–46.49 |
| 2026-06-29 | Walid Abi-Saab | Chief Medical Officer | Automatic Disposition | -20,000 | $46.40 |
| 2026-06-29 | Walid Abi-Saab | Chief Medical Officer | Derivative Exercise and Sale | -10,000 | $5.59–46.46 |
| 2026-06-25 | Walid Abi-Saab | Chief Medical Officer | Open Market Disposition | -1,434 | $46.86 |
| 2026-06-24 | Matthew Kapusta | Chief Executive Officer | Derivative Exercise and Sale | -32,844 | $31.71–50.02 |
| 2026-06-24 | Matthew Kapusta | Chief Executive Officer | Intent to Sell (Form 144) | -28,716 | $50.02 |
| 2026-06-23 | Matthew Kapusta | Chief Executive Officer | Automatic Disposition | -2,568 | $50.00 |
| 2026-06-17 | Matthew Kapusta | Chief Executive Officer | Automatic Disposition | -138,863 | $43.43–50.00 |
| 2026-06-17 | Matthew Kapusta | Chief Executive Officer | Derivative Exercise and Sale | -67,237 | $19.39–50.00 |
| 2026-06-17 | Matthew Kapusta | Chief Executive Officer | Intent to Sell (Form 144) | -41,671 | $46.38 |
| 2026-06-16 | Matthew Kapusta | Chief Executive Officer | Intent to Sell (Form 144) | -164,429 | $43.00 |
| 2026-06-16 | Jack Kaye | Independent Non-Executive Director | Derivative Exercise and Sale | -5,295 | $31.71–42.57 |
| 2026-06-16 | Madhavan Balachandran | Independent Non-Executive Director | Derivative Exercise and Sale | -11,685 | $19.39–47.08 |
| 2026-06-14 | Madhavan Balachandran | Independent Non-Executive Director | Derivative Exercise and Sale | -10,000 | $8.49–27.85 |
| 2026-06-14 | Jeannette Potts | Chief Legal & Compliance Officer | Open Market Disposition | -5,237 | $27.67 |
| 2026-06-10 | Leonard Post | Independent Non-Executive Director | Open Market Disposition | -1,993 | $27.06 |
| 2026-06-10 | Jack Kaye | Independent Non-Executive Director | Open Market Disposition | -1,993 | $27.06 |
| 2026-06-10 | Madhavan Balachandran | Independent Non-Executive Director | Open Market Disposition | -1,993 | $27.06 |
| 2026-06-10 | Jeremy Springhorn | Independent Non-Executive Director | Open Market Disposition | -1,993 | $27.06 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:25:46 · For reference only, not investment advice and not tailored to your situation.